These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1448 related items for PubMed ID: 16627016

  • 1. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [Abstract] [Full Text] [Related]

  • 2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 3. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH, Sifrim D, Lerut T, Janssens J, Tack J.
    Gut; 2008 Aug 15; 57(8):1056-64. PubMed ID: 18403496
    [Abstract] [Full Text] [Related]

  • 4. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB, Boparai V, Ullah N, Triadafilopoulos G.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):637-43. PubMed ID: 15352912
    [Abstract] [Full Text] [Related]

  • 5. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C, Going J, Neilson L, Mackay C, Stuart RC.
    Histopathology; 2005 Sep 15; 47(3):268-75. PubMed ID: 16115227
    [Abstract] [Full Text] [Related]

  • 6. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
    Bredenoord AJ, Hemmink GJ, Smout AJ.
    Neurogastroenterol Motil; 2009 Aug 15; 21(8):807-12. PubMed ID: 19374635
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus.
    Zentilin P, Conio M, Mele MR, Mansi C, Pandolfo N, Dulbecco P, Gambaro C, Tessieri L, Iiritano E, Bilardi C, Biagini R, Vigneri S, Savarino V.
    Aliment Pharmacol Ther; 2002 May 15; 16(5):893-8. PubMed ID: 11966497
    [Abstract] [Full Text] [Related]

  • 8. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F.
    Gut; 2008 Oct 15; 57(10):1354-9. PubMed ID: 18424568
    [Abstract] [Full Text] [Related]

  • 9. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Stoltey J, Reeba H, Ullah N, Sabhaie P, Gerson L.
    Aliment Pharmacol Ther; 2007 Jan 01; 25(1):83-91. PubMed ID: 17229223
    [Abstract] [Full Text] [Related]

  • 10. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A, Bird NC, Troy GP, Globe J, Johnson AG.
    Eur J Gastroenterol Hepatol; 1997 Dec 01; 9(12):1149-53. PubMed ID: 9471019
    [Abstract] [Full Text] [Related]

  • 11. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT, Barbezat GO.
    Q J Med; 1987 Feb 01; 62(238):97-108. PubMed ID: 3498962
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
    Frazzoni M, De Micheli E, Zentilin P, Savarino V.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):81-8. PubMed ID: 15225174
    [Abstract] [Full Text] [Related]

  • 13. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R.
    Aliment Pharmacol Ther; 2009 Sep 01; 30(5):508-15. PubMed ID: 19519732
    [Abstract] [Full Text] [Related]

  • 14. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
    Ortiz Escandell A, Martínez de Haro LF, Parrilla Paricio P, Molina Martínez J, Aguayo Albasini JL, Martínez Gómez D.
    Rev Esp Enferm Dig; 1990 Mar 01; 77(3):171-5. PubMed ID: 2378753
    [Abstract] [Full Text] [Related]

  • 15. The role of the hiatus hernia in gastro-oesophageal reflux disease.
    Gordon C, Kang JY, Neild PJ, Maxwell JD.
    Aliment Pharmacol Ther; 2004 Oct 01; 20(7):719-32. PubMed ID: 15379832
    [Abstract] [Full Text] [Related]

  • 16. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
    Willich SN, Nocon M, Kulig M, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P.
    Aliment Pharmacol Ther; 2006 Feb 01; 23(3):371-6. PubMed ID: 16422996
    [Abstract] [Full Text] [Related]

  • 17. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
    Dickman R, Parthasarathy S, Malagon IB, Jones P, Han B, Powers J, Fass R.
    Aliment Pharmacol Ther; 2007 Jul 01; 26(1):41-8. PubMed ID: 17555420
    [Abstract] [Full Text] [Related]

  • 18. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
    McDougall NI, Johnston BT, Collins JS, McFarland RJ, Love AH.
    Eur J Gastroenterol Hepatol; 1997 Dec 01; 9(12):1161-7. PubMed ID: 9471021
    [Abstract] [Full Text] [Related]

  • 19. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF, Rey JF, Caekaert A, Barthélemy P.
    Dig Liver Dis; 2005 Aug 01; 37(8):566-70. PubMed ID: 15886080
    [Abstract] [Full Text] [Related]

  • 20. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Feb 01; 38(2):85-90. PubMed ID: 16289976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.